Table 1 General characteristics of the participants with fibromyalgia and controls
Variables | Fibromyalgia n = 53 | Controls n = 50 | p-Value | ||
|---|---|---|---|---|---|
Mean ± SD | median (min-max) | Mean ± SD | median (min-max) | ||
Age (years) | 48.1 ± 8.2 | 49 (26–60) | 47.1 ± 9.9 | 50 (23–60) | 0.8018 |
BMI (Kg/m2) | 26.6 ± 4.5 | 26.8 (15.2–38.6) | 25.5 ± 3.6 | 24.9 (19.2–32.9) | 0.2123 |
Lean mass (%) | 60.4 ± 7.5 | 59.8 (43.8–82.1) | 60.2 ± 6.9 | 58.9 (48.4–77.9) | 0.89 |
Fat mass (%) | 39.6 ± 7.5 | 40.1 (18–56.2) | 39.8 ± 6.9 | 41.1 (22.1–51.6) | 0.877 |
Laboratory tests | |||||
Magnesium serum (mg/dL) | 2.2 ± 0.1 | 2.2 (1.8–2.6) | 2.2 ± 0.2 | 2.2 (1.8–2.6) | 0.577 |
Calcium serum (mg/dL) | 9.7 ± 0.5 | 9.6 (8.8–11.2) | 9.6 ± 0.4 | 9.7 (8.8–10.3) | 0.3163 |
US-CRP (mg/dL) | 0.3 ± 0.4 | 0.2 (< 0.09–1.9) | 0.3 ± 0.4 | 0.1 (< 0.09–2.6) | 0.454 |
TC (mg/dL) | 210.4 ± 35.4 | 207 (140–287) | 203.3 ± 30.4 | 201.5 (133–266) | 0.279 |
LDL (mg/dL) | 138.5 ± 30.8 | 135 (81–209) | 130.9 ± 27.7 | 129 (62–196) | 0.196 |
HDL (mg/dL) | 47.1 ± 11.1 | 46 (30–84) | 50.3 ± 12.2 | 49 (28–78) | 0.133 |
TG (mg/dL) | 123.6 ± 67.6 | 100 (35–311) | 110.6 ± 67.6 | 96 (44–427) | 0.283 |
Glycemia (mg/dL) | 82.9 ± 8.9 | 82 (59–101) | 83.9 ± 9.2 | 83 (60–103) | 0.593 |